ASN-51

N/A

Report date: 2025/03/04 20:00:11
NME

Base Information

Drug NameASN-51
Drug Alias NameASN-51
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAsceneuron SA
China Registration ClassN/A

Develop Information

Active CompaniesAsceneuron SA
Inactive CompaniesAsceneuron Pty Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A